Geneos Wealth Management’s FT Vest U.S. Equity Max Buffer ETF - November NOVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$404K Buy
11,980
+5,990
+100% +$200K 0.01% 803
2026
Q1
$196K Sell
5,990
-250
-4% -$8.23K ﹤0.01% 965
2025
Q4
$205K Hold
6,240
0.01% 917
2025
Q3
$201K Hold
6,240
0.01% 904
2025
Q2
$196K Sell
6,240
-6,260
-50% -$192K ﹤0.01% 1005
2025
Q1
$381K Buy
12,500
+6,250
+100% +$192K 0.01% 991
2024
Q4
$191K Buy
+6,250
New +$192K 0.01% 855

Other funds holding NOVM

Geneos Wealth Management's NOVM Position: Q2 2026 in Review

Geneos Wealth Management increased its FT Vest U.S. Equity Max Buffer ETF - November (NOVM) stake by 100% in Q2 2026, buying an estimated $200K and bringing the position to 11,980 shares worth $404K. The position accounts for 0.01% of the portfolio, ranked #803.

Geneos Wealth Management first reported a position in NOVM in Q4 2024 and has held it in 7 quarters since. 19 funds tracked by Wall St. Rank hold NOVM as of Q2 2026.

  • Geneos Wealth Management held 11,980 shares of FT Vest U.S. Equity Max Buffer ETF - November worth $404K as of Q2 2026.
  • Geneos Wealth Management bought 5,990 FT Vest U.S. Equity Max Buffer ETF - November shares in Q2 2026, an estimated $200K.
  • FT Vest U.S. Equity Max Buffer ETF - November made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #803 holding.
  • Geneos Wealth Management first reported a position in FT Vest U.S. Equity Max Buffer ETF - November in Q4 2024 and has held it in 7 quarters since.
  • 19 funds tracked by Wall St. Rank held FT Vest U.S. Equity Max Buffer ETF - November as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.